Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD Read more
ADC Therapeutics Announces the Termination of its ADCT-502 Program Targeting HER2 Expressing Solid Tumors Read more
Grand River Aseptic Manufacturing Expands Pharmaceutical Manufacturing Capacity with Major Equipment Purchase Read more
Noramco and SPI Pharma sign agreement to develop ready-to-implement, patient-friendly formulations for pharmaceutical manufacturers Read more